BlackRock Investment Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $973K | Buy |
6,901
+103
| +2% | +$14.5K | ﹤0.01% | 2703 |
|
2016
Q3 | $992K | Buy |
6,798
+560
| +9% | +$81.7K | ﹤0.01% | 2654 |
|
2016
Q2 | $628K | Buy |
6,238
+791
| +15% | +$79.6K | ﹤0.01% | 2920 |
|
2016
Q1 | $729K | Buy |
5,447
+93
| +2% | +$12.4K | ﹤0.01% | 2694 |
|
2015
Q4 | $1.06M | Buy |
5,354
+44
| +0.8% | +$8.74K | ﹤0.01% | 2557 |
|
2015
Q3 | $839K | Sell |
5,310
-1,294
| -20% | -$204K | ﹤0.01% | 2720 |
|
2015
Q2 | $2.7M | Buy |
6,604
+2,559
| +63% | +$1.04M | ﹤0.01% | 1998 |
|
2015
Q1 | $1.86M | Sell |
4,045
-580
| -13% | -$266K | ﹤0.01% | 2081 |
|
2014
Q4 | $2.6M | Sell |
4,625
-27
| -0.6% | -$15.2K | ﹤0.01% | 1841 |
|
2014
Q3 | $2.44M | Buy |
4,652
+456
| +11% | +$239K | ﹤0.01% | 1844 |
|
2014
Q2 | $2.93M | Buy |
4,196
+2,696
| +180% | +$1.88M | ﹤0.01% | 1777 |
|
2014
Q1 | $695K | Buy |
1,500
+177
| +13% | +$82K | ﹤0.01% | 2749 |
|
2013
Q4 | $455K | Buy |
+1,323
| New | +$455K | ﹤0.01% | 2979 |
|